Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Nephros (NEPH) FCF Margin (2016 - 2025)

Nephros (NEPH) has 16 years of FCF Margin data on record, last reported at 2.08% in Q3 2025.

  • For Q3 2025, FCF Margin rose 1979.0% year-over-year to 2.08%; the TTM value through Sep 2025 reached 15.12%, up 3039.0%, while the annual FY2024 figure was 3.92%, 920.0% down from the prior year.
  • FCF Margin reached 2.08% in Q3 2025 per NEPH's latest filing, down from 22.49% in the prior quarter.
  • Across five years, FCF Margin topped out at 33.49% in Q4 2024 and bottomed at 84.81% in Q1 2022.
  • Average FCF Margin over 5 years is 8.61%, with a median of 7.06% recorded in 2022.
  • Peak YoY movement for FCF Margin: skyrocketed 10390bps in 2021, then crashed -8196bps in 2022.
  • A 5-year view of FCF Margin shows it stood at 12.99% in 2021, then surged by 41bps to 7.62% in 2022, then decreased by -10bps to 8.39% in 2023, then surged by 499bps to 33.49% in 2024, then plummeted by -94bps to 2.08% in 2025.
  • Per Business Quant database, its latest 3 readings for FCF Margin were 2.08% in Q3 2025, 22.49% in Q2 2025, and 6.6% in Q1 2025.